CN1813979A - Collateral-flow-activating capsule - Google Patents
Collateral-flow-activating capsule Download PDFInfo
- Publication number
- CN1813979A CN1813979A CNA2005101292154A CN200510129215A CN1813979A CN 1813979 A CN1813979 A CN 1813979A CN A2005101292154 A CNA2005101292154 A CN A2005101292154A CN 200510129215 A CN200510129215 A CN 200510129215A CN 1813979 A CN1813979 A CN 1813979A
- Authority
- CN
- China
- Prior art keywords
- fructus
- cinnabaris
- capsule
- fine powder
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention belongs to the field of Chinese Tibetan medicine technology, in particular, it relates to an Ershiliuwei Tongjing capsule with the functions of regulating menstruation, activating collaterals, promoting blood circulation and removing blood stasis. Said capsule preparation is made up by using 26 Chinese medicinal materials of dalbergia wood, inula racemosa, madder root, chebule, lac, antelope horn and others through a certain preparation process.
Description
One, technical field: the invention belongs to the Tibetan medicine technical field, relate in particular to a kind of collateral-flow-activating capsule with activating collateral flow, promoting blood circulation to remove blood stasis function.
Two, technical background: at present, the technology identical or close with the present invention not the invention belongs to original invention.
Three, summary of the invention:
The objective of the invention is at the prior art above shortcomings, and develop a kind of collateral-flow-activating capsule, this capsule has activating collateral flow, promoting blood circulation to remove blood stasis, the effect of menstruction regulating and pain relieving.Be applicable to obstruction of collaterals by blood stasis, diseases such as menoxenia, amenorrhea, thoracic dorsal lower abdomen and flank pain.
Technical scheme is: the feature of this collateral-flow-activating capsule is: (one) raw material ratio is: Lignum Dalbergiae Odoriferae 3-60, Radix Inulae 3-60, ZANGQIANCAO 3-50, Fructus Chebulae 3-60, Lacca 3-50, Radix onosmatis 3-60, Cinnabaris 0.5-15, Cornu Saigae Tataricae 1.5-25, Fructus Hippophae extractum 3-60, Flos Carthami 3-60, Radix Pecteilis susannae 2.5-40, Fructus Phyllanthi 3-60, Rhizoma Dysosmae Versipellis 3-60, Fructus Malvae 3-50, BAXIAGA 3-50, Sal Nitri 1.5-25, Fructus Terminaliae Billericae 1.5-30, SHUHUABAOCHUN 1.5-30, Borax 1.5-30, Mirabilitum crystallina 2.5-40, tangut dragonhead 3-50, Fructus Tribuli 2.5-35, Folium Symplocoris Caudatae 2-30, Cortes seu Caulis Caraganae jubatae 5.5-90, Folium Paraquilegiae microphyllae 3-50, Saxifraga umbellulata Hook.f.et Thoms. 3-50, above-mentioned raw materials are the medical material that can be used as medicine; (2) manufacture method is: above-mentioned raw materials is prepared burden by said ratio, again this 20 Six-element medical material all the other 24 flavor raw material powders except that Cinnabaris, Cornu Saigae Tataricae are broken into fine powder, sieve with 〉=80 purpose standard screens, siftage fine powder mixing, Cinnabaris, Cornu Saigae Tataricae be porphyrize respectively, with siftage fine powder mixing, after sterilization, make capsule and get final product again.Raw material is meant that for the medical material that can be used as medicine raw material is clean, impurity can use as medical material less.Because of raw material of the present invention is 20 Six-elements, its effect is mainly dredge the meridian passage, so be named as collateral-flow-activating capsule.By prescription of the present invention, also it can be made tablet or other dosage form, it also belongs to protection scope of the present invention.
Capsule 's content of the present invention is tan powder, feeble QI perfume (or spice), and acrid in the mouth, bitterness, it has activating collateral flow, blood circulation promoting and blood stasis dispelling, the effect of menstruction regulating and pain relieving, it is applicable to obstruction of collaterals by blood stasis, diseases such as menoxenia, amenorrhea, thoracic dorsal lower abdomen and flank pain.When taking each 3～4, every day 2 times.Because of containing Cinnabaris in this product, should not take for a long time, hepatic and kidney function obstacle, disease of hematopoietic system, anemia of pregnant woman and women breast-feeding their children's forbidding.
Four, the specific embodiment:
Embodiment one: get Lignum Dalbergiae Odoriferae 3g, Radix Inulae 3g, ZANGQIANCAO 3g, Fructus Chebulae 3g, Lacca 3g, Radix onosmatis 3g, Cinnabaris 0.5g, Cornu Saigae Tataricae 1.5g, Fructus Hippophae extractum 3g, Flos Carthami 3g, Radix Pecteilis susannae 2.5g, Fructus Phyllanthi 3g, Rhizoma Dysosmae Versipellis 3g, Fructus Malvae 50g, BAXIAGA 50g, Sal Nitri 25g, Fructus Terminaliae Billericae 30g, SHUHUABAOCHUN 30g, Borax 30g, Mirabilitum crystallina 40g, tangut dragonhead 50g, Fructus Tribuli 35g, Folium Symplocoris Caudatae 30g, Cortes seu Caulis Caraganae jubatae 90g, Folium Paraquilegiae microphyllae 50g, Saxifraga umbellulata Hook.f.et Thoms. 50g prepares burden, and this 20 Six-element raw material is removed Cinnabaris, all the other outer 24 flavor raw material powders of Cornu Saigae Tataricae are broken into fine powder, sieve with 80 purpose standard screens, siftage fine powder mixing, again with Cinnabaris, Cornu Saigae Tataricae is ground into fine powder respectively, again with siftage fine powder mixing, makes capsule product after sterilization.
Embodiment two: get Lignum Dalbergiae Odoriferae 60g, Radix Inulae 60g, ZANGQIANCAO 50g, Fructus Chebulae 60g, Lacca 50g, Radix onosmatis 60g, Cinnabaris 15g, Cornu Saigae Tataricae 25g, Fructus Hippophae extractum 60g, Flos Carthami 60g, Radix Pecteilis susannae 40g, Fructus Phyllanthi 60g, Rhizoma Dysosmae Versipellis 60g, Fructus Malvae 3g, BAXIAGA 3g, Sal Nitri 1.5g, Fructus Terminaliae Billericae 1.5g, SHUHUABAOCHUN 1.5g, Borax 1.5g, Mirabilitum crystallina 2.5g, tangut dragonhead 3g, Fructus Tribuli 2.5g, Folium Symplocoris Caudatae 2g, Cortes seu Caulis Caraganae jubatae 5.5g, Folium Paraquilegiae microphyllae 3g, Saxifraga umbellulata Hook.f.et Thoms. 3g prepares burden, and this 20 Six-element raw material is removed Cinnabaris, all the other outer 24 flavor raw material powders of Cornu Saigae Tataricae are broken into fine powder, with the screening of 120 purpose standard screens, remaining manufacture method is identical with embodiment one.
Claims (1)
1. collateral-flow-activating capsule, it is characterized in that: (one) raw material ratio is: Lignum Dalbergiae Odoriferae 3-60, Radix Inulae 3-60, ZANGQIANCAO 3-50, Fructus Chebulae 3-60, Lacca 3-50, Radix onosmatis 3-60, Cinnabaris 0.5-15, Cornu Saigae Tataricae 1.5-25, Fructus Hippophae extractum 3-60, Flos Carthami 3-60, Radix Pecteilis susannae 2.5-40, Fructus Phyllanthi 3-60, Rhizoma Dysosmae Versipellis 3-60, Fructus Malvae 3-50, BAXIAGA 3-50, Sal Nitri 1.5-25, Fructus Terminaliae Billericae 1.5-30, SHUHUABAOCHUN 1.5-30, Borax 1.5-30, Mirabilitum crystallina 2.5-40, tangut dragonhead 3-50, Fructus Tribuli 2.5-35, Folium Symplocoris Caudatae 2-30, Cortes seu Caulis Caraganae jubatae 5.5-90, Folium Paraquilegiae microphyllae 3-50, Saxifraga umbellulata Hook.f.et Thoms. 3-50, above-mentioned raw materials are the medical material that is used as medicine; (2) manufacture method is: above-mentioned raw materials is prepared burden by said ratio, again this 20 Six-element medical material all the other 24 flavor raw material powders except that Cinnabaris, Cornu Saigae Tataricae are broken into fine powder, sieve with 〉=80 purpose standard screens, siftage fine powder mixing, Cinnabaris, Cornu Saigae Tataricae be porphyrize respectively, with siftage fine powder mixing, after sterilization, make capsule and get final product again.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2005101292154A CN1813979A (en) | 2005-11-29 | 2005-11-29 | Collateral-flow-activating capsule |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2005101292154A CN1813979A (en) | 2005-11-29 | 2005-11-29 | Collateral-flow-activating capsule |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1813979A true CN1813979A (en) | 2006-08-09 |
Family
ID=36906411
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2005101292154A Pending CN1813979A (en) | 2005-11-29 | 2005-11-29 | Collateral-flow-activating capsule |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1813979A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102246698A (en) * | 2011-06-30 | 2011-11-23 | 西安文理学院 | Aquilegia tissue culture medium and rapid reproduction method |
| CN102441156A (en) * | 2011-12-14 | 2012-05-09 | 多吉 | Traditional Tibetan medicinal composition and preparation method thereof |
| CN102590430A (en) * | 2012-01-17 | 2012-07-18 | 西藏奇正藏药股份有限公司 | Method for detecting liuwei caragana preparation |
| CN102590426A (en) * | 2012-03-29 | 2012-07-18 | 山东阿如拉药物研究开发有限公司 | Quality detection method for medicinal composition twenty five-ingredient rhizoma podophylli emodi pills and preparation thereof |
| CN103933441A (en) * | 2014-05-15 | 2014-07-23 | 刘善奎 | Traditional Chinese medicinal suppository for treating cervicitis and preparation method thereof |
| CN103990101A (en) * | 2014-06-13 | 2014-08-20 | 薛枫 | Traditional Chinese medicine composition for treating gynecological disease |
| CN105079557A (en) * | 2015-09-09 | 2015-11-25 | 白玛仁增 | Compound Tibetan medicine for treating gynecological uterine fibroid |
-
2005
- 2005-11-29 CN CNA2005101292154A patent/CN1813979A/en active Pending
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102246698A (en) * | 2011-06-30 | 2011-11-23 | 西安文理学院 | Aquilegia tissue culture medium and rapid reproduction method |
| CN102441156A (en) * | 2011-12-14 | 2012-05-09 | 多吉 | Traditional Tibetan medicinal composition and preparation method thereof |
| CN102441156B (en) * | 2011-12-14 | 2013-06-12 | 多吉 | Traditional Tibetan medicinal composition and preparation method thereof |
| CN102590430A (en) * | 2012-01-17 | 2012-07-18 | 西藏奇正藏药股份有限公司 | Method for detecting liuwei caragana preparation |
| CN102590430B (en) * | 2012-01-17 | 2014-08-13 | 西藏奇正藏药股份有限公司 | Method for detecting liuwei caragana preparation |
| CN102590426A (en) * | 2012-03-29 | 2012-07-18 | 山东阿如拉药物研究开发有限公司 | Quality detection method for medicinal composition twenty five-ingredient rhizoma podophylli emodi pills and preparation thereof |
| CN103933441A (en) * | 2014-05-15 | 2014-07-23 | 刘善奎 | Traditional Chinese medicinal suppository for treating cervicitis and preparation method thereof |
| CN103990101A (en) * | 2014-06-13 | 2014-08-20 | 薛枫 | Traditional Chinese medicine composition for treating gynecological disease |
| CN105079557A (en) * | 2015-09-09 | 2015-11-25 | 白玛仁增 | Compound Tibetan medicine for treating gynecological uterine fibroid |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102266445B (en) | Eye protection Chinese medicinal composition with health care and treatment effects | |
| CN1813979A (en) | Collateral-flow-activating capsule | |
| CN104826016B (en) | A kind of pharmaceutical composition and its preparation method and application for treating the proliferation of mammary gland | |
| CN1305514C (en) | Qishiwei Turguoise pills | |
| CN105125689B (en) | A kind of lavipeditum powder containing the FUKE QIANJIN PIAN dregs of a decoction and preparation method thereof | |
| CN101041036A (en) | Medicine liquid for reducing pain for external application | |
| JPH02188528A (en) | Remedy for dementia | |
| CN107007735A (en) | Medicine perfume (or spice) dirty for aligning and preparation method thereof | |
| CN102133167B (en) | Freckle removing facial mask made of traditional Chinese medicine and preparation process thereof | |
| CN100490871C (en) | Combination of Chinese traditional medicine for curing chronic pharyngitis and preparation method | |
| CN103285329B (en) | Medicament for treating women dysmenorrhea and preparation method thereof | |
| CN104189592A (en) | Traditional Chinese medicine preparation for treating teenager white hair | |
| CN1634213A (en) | Chinese medicinal formulation for hematogenesis | |
| CN103989762B (en) | Chinese medicine composition of internal organs relieving cough and resolving phlegm and preparation method thereof is rushed down in a kind of heat clearing away | |
| CN1315186A (en) | Medical tea for treating leukoderma and its preparing process | |
| CN1192922A (en) | Preparatory Chinese-medicine for treatment of hepatitis and hepatoascites | |
| CN100488495C (en) | A Chinese medicinal preparation for treating rheumatism, hyperosteogeny and osteoporosis and method for preparing same | |
| CN1406617A (en) | Tablets against allergic purpura | |
| CN101549067B (en) | Chinese medicinal composition and uses thereof | |
| CN1037661C (en) | Dental pain-relieving Chinese medicine composite | |
| CN1426779A (en) | Chinese medicine raw material in form of particles and its preparation method | |
| CN100534485C (en) | Preparation prepared by biological chitin and traditional Chinese medicine for postponing senescence | |
| CN101991762A (en) | Traditional Chinese medicine for treating refractory asthma and preparation method thereof | |
| CN100350960C (en) | Traditional Chinese medicinal prepn. for treating biailary calculi | |
| CN1306928C (en) | Chinese traditional medicine for treating laryngopharyngeal paresthesia and its preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |